title: Commentary on "The risky business of studying prognosis".
authors.affiliation: Division of Rheumatology, Albert Einstein College of Medicine, Forchheimer 701N, 1300 Morris Park Ave., Bronx, New York 10461, USA.
authors.forename: Anna
authors.initials: A
authors.lastname: Broder
authors.forename: Chaim
authors.initials: C
authors.lastname: Putterman
mesh_terms: D017152:Antibodies, Antiphospholipid / Q000276:immunology*; D016736:Antiphospholipid Syndrome / Q000276:immunology*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000276:immunology*; D008297:Male
chemical_list: D017152:Antibodies, Antiphospholipid; D018501:Antirheumatic Agents; D006886:Hydroxychloroquine